ObsEva (NASDAQ:OBSV) Coverage Initiated at StockNews.com

StockNews.com assumed coverage on shares of ObsEva (NASDAQ:OBSV) in a research note published on Saturday. The brokerage issued a hold rating on the stock.

ObsEva Stock Performance

NASDAQ OBSV opened at $0.01 on Friday. The stock’s fifty day moving average is $0.02 and its two-hundred day moving average is $0.04. The firm has a market capitalization of $389,855.00, a P/E ratio of -0.01 and a beta of 0.68. ObsEva has a fifty-two week low of $0.08 and a fifty-two week high of $2.14.

ObsEva Company Profile

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.